TAMPER-EVIDENT PACKAGING ON MULTIDOSE PRODUCTS

To support the standardization and requirement of tamper-evident packaging on all multidose prescription and nonprescription products; further,

To encourage proper safety controls be in place to prevent harm and ensure proper disposal of multidose products.

Rationale

Multidose products provide more than one dose of a medication. Medications available in multidose forms include but are not limited to topical creams, gels, and ointments, inhalers, and solutions. Tamper-evident packaging is needed to ensure the viability and safety of medications in multidose containers. The Food and Drug Administration defines a tamper-evident package as “one having one or more indicators or barriers to entry which, if breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering occurred.” In addition, when multidose products are disposed of, best practices in medication waste disposal need to be employed to prevent harm or diversion.